The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tarsus Pharmaceuticals Inc shares valued at $300,000 were sold by Azamian Bobak R. on Aug 11 ’25. At $50.00 per share, Azamian Bobak R. sold 6,000 shares. The insider’s holdings dropped to 818,106 shares worth approximately $44.29 million following the completion of this transaction.
Also, Azamian Bobak R. purchased 6,000 shares, netting a total of over 300,000 in proceeds.
Before that, Farrow Jeffrey S had sold 13,608 shares from its account. In a trade valued at $550,035, the insider traded Tarsus Pharmaceuticals Inc shares for $40.42 each. Upon closing the transaction, the insider’s holdings decreased to 13,608 shares, worth approximately $1.99 million.
As of November 20, 2023, Goldman has initiated its “Neutral” rating for TARS. Earlier on July 18, 2023, William Blair initiated its rating. Their recommendation was “an Outperform” for TARS stock.
Analyzing TARS Stock Performance
On last trading session, Tarsus Pharmaceuticals Inc [NASDAQ: TARS] rose 2.69% to $54.14. The stock’s lowest price that day was $51.8, but it reached a high of $54.29 in the same session. During the last five days, there has been a surge of approximately 12.91%. Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 106.56%. Shares of the company reached a 52-week high of $57.28 on 02/05/25 and a 52-week low of $38.51 on 08/01/25.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 52.53, which, if violated, would cause prices to drop to 50.92. In the upper region, resistance lies at 55.02. The next price resistance is at 55.90. RSI (Relative Strength Index) is 78.54 on the 14-day chart, showing overbought technical sentiment.
Is Tarsus Pharmaceuticals Inc subject to short interest?
Stocks of Tarsus Pharmaceuticals Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.72 million shares to 8.14 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 8.86 million shares. A decline of -8.85% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 14.42 of the overall float, the days-to-cover ratio (short ratio) decline to 14.42.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
In terms of Tarsus Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 71 in the next 12 months, up nearly 34.67% from the previous closing price of $52.72. Analysts anticipate Tarsus Pharmaceuticals Inc stock to reach 84 by 2025, with the lowest price target being 58. In spite of this, 4 analysts ranked Tarsus Pharmaceuticals Inc stock as Buy at the end of 2025.
